NEW YORK, April 24-Cytogen subsidiary AxCell Biosciences said today that it will partner with researchers at the University of Muenster to research proteins involved in neurodegenerative disease.
AxCell will provide data from its signal transduction database, and the research will seek to understand the signaling pathway of a neuronal protein thought to be involved in degenerative disorders and Alzheimer's disease.
Under the deal, discoveries will be the joint property of the university and the company. AxCell retains an option to negotiate an exclusive, worldwide, royalty-bearing license from the university for any discoveries.
AxCell did not name the gene that would be the focus of this research, but said that the work would be led by Joachim Kremerskothen and Angelika Barnelow, who study neuronal proteins produced by dendritic-localized mRNAs. Normal transcription of dendritic mRNA, said the company, is essential for learning and memory.